AVIVA STRATEGIES (FKA MGB CONSULTING)

Lobbying for BEAM THERAPEUTICS · Biotechnology & drug development

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $51,000.00 income · posted Jan 15, 2026

Lobbying activity 1

Health Issues

-cell and gene therapy policy

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem